SLC27A2 has been reported to regulate the tumor suppressor gene PARP, with reduced levels of SLC27A2 expression in metastatic tumors compared to non-metastatic neuroendocrine tumors (25). This evidence concerns the gene SLC27A2 and metastatic neoplasm.